Medizinische Hochshule Hannover
Welcome,         Profile    Billing    Logout  
 3 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Prasse, Antje
NCT05130970 / 2021-003162-12: CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Completed
2
81
Europe, Canada, US, RoW
CSL312, Factor XIIa antagonist monoclonal antibody, Garadacimab, Placebo
CSL Behring
Idiopathic Pulmonary Fibrosis
01/24
01/24
NCT06472362: Chest CT Biomarkers as Prognostic Predictors in SSc-ILD

Not yet recruiting
N/A
1000
Europe
HRCT biomarkers
Royal Brompton & Harefield NHS Foundation Trust, Imperial College London, Royal Free and University College Medical School, The Leeds Teaching Hospitals NHS Trust, Hannover Medical School, University of Siena, Università Politecnica delle Marche, Azienda Ospedaliero Universitaria di Sassari, Bichat Hospital
Systemic Sclerosis
06/25
03/26

Download Options